FibroBiologics is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal. We show 4 historical shares outstanding datapoints in our FBLG shares outstanding history coverage, used to compute FBLG market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing FBLG market cap history over the course of time is important for investors
interested in comparing FBLG's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of FBLG versus a peer is one thing; comparing
FBLG market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like FBLG can fluctuate over the course of history.
With this page we aim to empower investors researching FBLG by allowing them to research the FBLG market cap history. |
Free FBLG Email Alerts:
Video: The Importance of Market Cap
